Management of Low Serum Iron in Males
A male with a total serum iron of 65 μg/dL should undergo a complete iron status evaluation including ferritin, transferrin saturation, and complete blood count to determine the presence and severity of iron deficiency before initiating treatment. 1
Diagnostic Approach
Initial Assessment
- Serum iron alone is insufficient for diagnosis as it has high day-to-day variation and is affected by multiple factors including meals, inflammation, and diurnal variation 1
- A comprehensive iron panel should include:
Diagnostic Criteria
- Iron deficiency is likely if:
Additional Testing
- If anemia is present (Hb <13 g/dL in males), evaluate for other causes 1
- Consider soluble transferrin receptor or reticulocyte hemoglobin content if results are inconclusive 1
- Bone marrow iron staining remains the gold standard but is rarely needed 1
Treatment Algorithm
If Iron Deficiency Without Anemia is Confirmed:
Initiate oral iron supplementation 5
If Iron Deficiency Anemia is Confirmed:
More urgent GI evaluation is warranted in males with iron deficiency anemia 1, 3
Consider parenteral iron if: 1, 6
- Oral iron is not tolerated
- Malabsorption is present
- Blood loss exceeds oral absorption capacity
- Rapid repletion is needed
Monitoring Response
Check hemoglobin after 1 month of therapy 4
Special Considerations
- Low serum iron with normal or elevated ferritin suggests anemia of chronic disease rather than iron deficiency 1
- In athletes, particularly endurance athletes, iron deficiency without anemia may still impact performance 1
- For patients with heart failure and iron deficiency, intravenous iron may be beneficial even without anemia 1
Common Pitfalls
- Relying solely on serum iron for diagnosis (high variability and low specificity) 1
- Failing to investigate underlying cause in adult males (GI malignancy risk) 1, 3
- Inadequate duration of treatment (need to replenish stores after correcting anemia) 2, 6
- Misinterpreting iron studies in the presence of inflammation (ferritin is an acute phase reactant) 1